View Document Preview and Link Document Date: 2011-08-23 10:27:56 Open Document File Size: 925,29 KB Share Result on Facebook
City Brussels / / Company AEs / European Biopharmaceutical Enterprises / / Continent Europe / / Country Belgium / United States / United Kingdom / / / Event Product Issues / / Facility Leopold Plaza Building / / IndustryTerm generic medicinal products / reference medicinal product / similar biological products / biological products / originator products / healthcare community / biotechnology / biosimilar and interchangeable products / healthcare delivery system / biotechnology products / product-class/product / comparator product / reference product / molecule medicinal products / biological product / interchangeable biological products / particular product / proposed interchangeable biological product / particular biosimilar product / medicinal products / proposed biosimilar product / qualified healthcare professional / biological and biosimilar products / given product / biopharmaceutical / healthcare professionals / biosimilar manufacturing process / related biological product / biosimilar product / interchangeable product / biosimilar products / manufacturing / biotechnology arm / given reference product / similar biological medicinal products / / Organization World Health Organization / European Association for Bioindustries / European Commission / FDA / European Court of Justice / European Federation of Pharmaceutical Industries and Associations / EBE / European Union / / Person Nicolas Rossignol / / Position pharmacist / physician / EMA Executive Director / Administrator / / Product data / / ProgrammingLanguage EC / / ProvinceOrState Massachusetts / / PublishedMedium Extrapolation / / Technology biotechnology / jsp / / URL http / SocialTag 
21 December[removed]FDA REQUEST FOR COMMENTS ON “APPROVAL PATHWAY FOR BIOSIMILAR AND INTERCHANGEABLE BIOLOGICAL PRODUCTS” EUROPABIO and EBE comments